EXELIXIS, INC. (EXEL) Form 10-K Annual Reports
EXELIXIS, INC. (EXEL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EXEL
CIK: 939767
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 01/01
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/30/2016 12:00:00 AM
Lead Engagement PartnerRichard Shunn
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-11 | 2026-09-10 | 8-K | 0000939767-26-000108 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | 8-K | 0000939767-26-000104 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-14 | — | SCHEDULE 13D/A Filing | 0000908834-26-000419 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0000939767-26-000101 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0001167557-26-000125 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007854 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | S-8 | 0000939767-26-000100 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-07-03 | 10-Q | 0000939767-26-000098 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0000939767-26-000096 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000939767-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000939767-26-000084 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001969223-26-000611 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001950047-26-005335 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000083 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000082 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000081 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000080 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000079 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000078 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000077 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000076 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0000939767-26-000075 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0000902664-26-002641 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-26 | 8-K | 0000939767-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | FORM 4 | 0000939767-26-000070 | View SEC Doc Filr Page |